CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 414 filers reported holding CRISPR THERAPEUTICS AG in Q4 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,622,273 | -23.7% | 520,429 | -5.6% | 0.00% | 0.0% |
| Q2 2023 | $30,955,317 | +17.5% | 551,395 | -5.4% | 0.00% | 0.0% |
| Q1 2023 | $26,353,064 | +109841.9% | 582,664 | -1.2% | 0.00% | 0.0% |
| Q4 2022 | $23,970 | -99.9% | 589,623 | -3.8% | 0.00% | -50.0% |
| Q3 2022 | $40,052,000 | -0.6% | 612,890 | -7.6% | 0.01% | 0.0% |
| Q2 2022 | $40,294,000 | -0.7% | 663,060 | +2.6% | 0.01% | +20.0% |
| Q1 2022 | $40,586,000 | -30.6% | 646,572 | -16.2% | 0.01% | -28.6% |
| Q4 2021 | $58,495,000 | -18.9% | 771,899 | +19.8% | 0.01% | -22.2% |
| Q3 2021 | $72,150,000 | -22.3% | 644,586 | +12.4% | 0.01% | -18.2% |
| Q2 2021 | $92,818,000 | +38.4% | 573,341 | +4.2% | 0.01% | +22.2% |
| Q1 2021 | $67,067,000 | -3.0% | 550,410 | +21.9% | 0.01% | -10.0% |
| Q4 2020 | $69,154,000 | +100.0% | 451,660 | +11.0% | 0.01% | +66.7% |
| Q3 2020 | $34,576,000 | +90.2% | 406,815 | +64.5% | 0.01% | +50.0% |
| Q2 2020 | $18,176,000 | +120.2% | 247,334 | +27.1% | 0.00% | +100.0% |
| Q1 2020 | $8,254,000 | -43.2% | 194,615 | -18.4% | 0.00% | -33.3% |
| Q4 2019 | $14,534,000 | +7630.9% | 238,629 | +5083.1% | 0.00% | – |
| Q3 2019 | $188,000 | -96.8% | 4,604 | -96.5% | 0.00% | -100.0% |
| Q2 2019 | $5,967,000 | +3851.7% | 131,537 | +3028.9% | 0.00% | – |
| Q1 2019 | $151,000 | -89.8% | 4,204 | -91.9% | 0.00% | – |
| Q4 2018 | $1,479,000 | -89.6% | 51,757 | -83.9% | 0.00% | -100.0% |
| Q3 2018 | $14,213,000 | +357.9% | 320,483 | +506.8% | 0.00% | +200.0% |
| Q2 2018 | $3,104,000 | +23.0% | 52,811 | -50.8% | 0.00% | 0.0% |
| Q4 2017 | $2,523,000 | +370.7% | 107,444 | +250.5% | 0.00% | – |
| Q3 2017 | $536,000 | – | 30,657 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |